Sabrina Maria Witherby MD
Breast Cancer
Assistant Professor of Medicine, Brown University Health Cancer Institute
Join to View Full Profile
164 Summit AvenueMiriam HospitalProvidence, RI 02906
Dr. Witherby is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Sabrina Witherby, MD is an oncologist based in Providence, RI, with a subspecialty in breast cancer. A graduate from the University of Massachusetts Medical School in 2001, she completed a residency in Internal Medicine at Brown University (2001-2004) and a fellowship in Hematology and Medical Oncology at the University of Vermont Medical Center (2004-2007). Dr. Witherby is board certified in hematology/oncology but sees primarily breast cancer patients and focuses on medical education.
Education & Training
University of Vermont Medical CenterFellowship, Hematology and Medical Oncology, 2004 - 2007
Rhode Island Hospital/Brown University HealthResidency, Internal Medicine, 2001 - 2004
University of Massachusetts Medical SchoolClass of 2001
Certifications & Licensure
MA State Medical License 2017 - 2026
RI State Medical License 2007 - 2026
VT State Medical License 2004 - 2008
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Vaginal Testosterone Cream For Atrophic Vaginitis in Women Taking Aromatase Inhibitors for Breast Cancer. Start of enrollment: 2006 Dec 01
Publications & Presentations
PubMed
- Fulfilling the Role of a Parent While Undergoing Treatment for Cancer: A Review of the Literature and the Potential Impact of Childcare Support on Cancer Outcomes.Kang Woo Kim, Mary Lopresti, Stephanie L Graff, Sabrina Witherby, Don S Dizon
American Journal of Clinical Oncology. 2024-09-01 - 2 citationsNeoadjuvant weekly paclitaxel and carboplatin with trastuzumab and pertuzumab in HER2-positive breast cancer: a Brown University Oncology Research Group (BrUOG) study.Mary L Lopresti, Jessica J Bian, Bachir J. Sakr, Rochelle Strenger, Robert D. Legare
Breast Cancer Research and Treatment. 2021-06-04 - 6 citationsDistress: Characterizing What Causes the Thermometer to Shift in Patients with Newly Diagnosed Breast Cancer Attending a Multidisciplinary ClinicChelsey C Ciambella, Charu Taneja, Don S. Dizon, Doreen L Wiggins, Christine M Emmick
Annals of Surgical Oncology. 2019-07-24
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
